Ahrong Kim

1.4k total citations · 1 hit paper
49 papers, 905 citations indexed

About

Ahrong Kim is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Ahrong Kim has authored 49 papers receiving a total of 905 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 18 papers in Surgery and 18 papers in Oncology. Recurrent topics in Ahrong Kim's work include Cancer Immunotherapy and Biomarkers (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Sarcoma Diagnosis and Treatment (6 papers). Ahrong Kim is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Gastric Cancer Management and Outcomes (8 papers) and Sarcoma Diagnosis and Treatment (6 papers). Ahrong Kim collaborates with scholars based in South Korea and United States. Ahrong Kim's co-authors include Do Youn Park, Kyung Un Choi, Gi Yeong Huh, Chungsu Hwang, So Jeong Lee, Won Young Park, Jee Yeon Kim, Chang Hun Lee, Gyungyub Gong and Sangjeong Ahn and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Ahrong Kim

47 papers receiving 890 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A multimodal generative AI copilot for human pathology

2024 156 citations Ming Y. Lu, Bowen Chen et al. Nature profile →

Peers

Countries citing papers authored by Ahrong Kim

Since Specialization

Citations

This map shows the geographic impact of Ahrong Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahrong Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahrong Kim more than expected).

Fields of papers citing papers by Ahrong Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahrong Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahrong Kim. The network helps show where Ahrong Kim may publish in the future.

Co-authorship network of co-authors of Ahrong Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Ahrong Kim. A scholar is included among the top collaborators of Ahrong Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahrong Kim. Ahrong Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Breast fine-needle aspiration cytology in the era of core-needle biopsy: what is its role? 2025 ·Journal of Pathology and Translational Medicine ·Ahrong Kim, Hyun Jung Lee, Jee Yeon Kim	1
2	Impact of Neoadjuvant Chemotherapy (NAC) on Biomarker Expression in Breast Cancer 2024 ·Medicina ·(unknown), Jee Yeon Kim, So Jeong Lee, Chungsu Hwang, Hyun Jung Lee, (unknown), (unknown), Dong‐Hoon Shin, Kyung Un Choi, Chang Hun Lee, Gi Yeong Huh, Ahrong Kim	2
3	A multimodal generative AI copilot for human pathology breakdown → 2024 ·Nature ·Ming Y. Lu, Bowen Chen, Drew F. K. Williamson, Richard J. Chen, Melissa Zhao, (unknown), Kenji Ikemura, Ahrong Kim, Dimitra Pouli, Ankush Patel, (unknown), Chengkuan Chen, Tong Ding, Judy J. Wang, Georg K. Gerber, Ivy Liang, Long P. Le, Anil V. Parwani, Luca L. Weishaupt, Faisal Mahmood	156
4	Programmed Death Ligand 1 Immunohistochemistry in Triple-Negative Breast Cancer: Evaluation of Inter-Pathologist Concordance and Inter-Assay Variability 2021 ·Journal of Breast Cancer ·Soomin Ahn, Ji Won Woo, Hyojin Kim, Eun Yoon Cho, Ahrong Kim, Jee Yeon Kim, Chungyeul Kim, Hee Jin Lee, Ji Shin Lee, Young Kyung Bae, Youngmee Kwon, Wan Seop Kim, So Yeon Park	14
5	Differences in immune-related gene expressions and tumor-infiltrating lymphocytes according to chemotherapeutic response in ovarian high-grade serous carcinoma 2020 ·Journal of Ovarian Research ·Kyung Un Choi, Ahrong Kim, Jee Yeon Kim, Ki Hyung Kim, Chungsu Hwang, (unknown), Won Young Park, (unknown), Hye Jeong Choi, (unknown)	14
6	The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma 2019 ·PLoS ONE ·Ahrong Kim, So Jeong Lee, Jihyun Ahn, Won Young Park, Dong‐Hoon Shin, Chang Hun Lee, (unknown), Yeon Joo Jeong, Hyo Yeong Ahn, I Hoseok, Yeong Dae Kim, Jeong Su Cho	30
7	Bronchoscopic management of solitary bronchial myelolipoma: a case report 2019 ·BMC Pulmonary Medicine ·(unknown), (unknown), Jung Seop Eom, (unknown), Seyeon Park, Jihyun Ahn, Ahrong Kim, Chang Hun Lee, Geewon Lee, Min Ki Lee	2
8	Diffusion tensor magnetic resonance imaging of breast cancer: associations between diffusion metrics and histological prognostic factors 2018 ·European Radiology ·Jin You Kim, Jin Joo Kim, Suk Kim, Ki Seok Choo, Ahrong Kim, Taewoo Kang, Heesung Park	22
9	The significance of tumor budding in T1 colorectal carcinoma: the most reliable predictor of lymph node metastasis especially in endoscopically resected T1 colorectal carcinoma 2018 ·Human Pathology ·So Jeong Lee, Ahrong Kim, (unknown), Won Young Park, Hyun Sung Kim, Hong-Jae Jo, (unknown), (unknown), Do Youn Park	26
10	Differential MicroRNA Expression between EGFR T790M and L858R Mutated Lung Cancer 2018 ·Journal of Pathology and Translational Medicine ·(unknown), (unknown), Ha Young Park, Ahrong Kim, Dong‐Hoon Shin, Chang Hun Lee	6
11	A peculiar case report of extraovarian Brenner tumor arising in the omentum 2017 ·World Journal of Surgical Oncology ·Chungsu Hwang, Chang‐Hun Lee, So Jeong Lee, (unknown), Ahrong Kim, Do Youn Park, (unknown), Dong‐Hoon Shin	6
12	Programmed death-ligand 1 (PD-L1) expression in tumour cell and tumour infiltrating lymphocytes of HER2-positive breast cancer and its prognostic value 2017 ·Scientific Reports ·Ahrong Kim, So Jeong Lee, (unknown), Won Young Park, Do Youn Park, Jee Yeon Kim, Chang Hun Lee, Gyungyub Gong, Gi Yeong Huh, Kyung Un Choi	61
13	Occurrence of metachronous or synchronous lesions after endoscopic treatment of gastric epithelia dysplasia- impact of histologic features of background mucosa 2017 ·Pathology - Research and Practice ·(unknown), (unknown), (unknown), Ahrong Kim, Do Youn Park, (unknown), (unknown), Gwang Ha Kim	8
14	Three cases of adrenocortical tumors mistaken for hepatocellular carcinomas/diagnostic pitfalls and differential diagnosis 2017 ·Annals of Diagnostic Pathology ·Won Young Park, Hyung Il Seo, Kyung Un Choi, Ahrong Kim, (unknown), So Jeong Lee, Chang Hun Lee, Gi Yeong Huh, Do Youn Park	18
15	Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)–Positive Breast Cancers 2016 ·Cancer Research and Treatment ·So Jeong Lee, (unknown), (unknown), Hyun Jung Lee, Sangjeong Ahn, Nari Shin, (unknown), Dong Hoon Shin, Kyung Un Choi, Do Youn Park, Chang Hun Lee, (unknown), (unknown), Hee Jin Lee, Gyungyub Gong, Jee Yeon Kim, Ahrong Kim	9
16	An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes 2016 ·American Journal of Clinical Pathology ·Ahrong Kim, Sun‐Hee Heo, Young‐Ae Kim, Gyungyub Gong, Hee Jin Lee	23
17	Risk of lymph node metastasis in mixed-type early gastric cancer determined by the extent of the poorly differentiated component 2016 ·World Journal of Gastroenterology ·Chungsu Hwang, Sangjeong Ahn, (unknown), (unknown), Ahrong Kim, Chang In Choi, Dae Hwan Kim, Tae‐Yong Jeon, Gwang Ha Kim, (unknown), Do Youn Park	25
18	Venous Invasion in Colorectal Cancer: Impact of Morphologic Findings on Detection Rate 2016 ·Cancer Research and Treatment ·Chungsu Hwang, Sojeong Lee, Ahrong Kim, (unknown), Sangjeong Ahn, Do Youn Park	15
19	Prognostic significance of WT1 expression in soft tissue sarcoma 2014 ·World Journal of Surgical Oncology ·Ahrong Kim, Eunyoung Park, (unknown), Jeong Hee Lee, Dong‐Hoon Shin, Jee Yeon Kim, Do Youn Park, Chang Hun Lee, Mee Young Sol, Kyung Un Choi, Jeung Il Kim, In Sook Lee	7
20	Adenocarcinoma with sarcomatous dedifferentiation arising from mature cystic teratoma of the anterior mediastinum 2012 ·Pathology - Research and Practice ·Jee-Yeon Kim, Chang‐Hun Lee, (unknown), (unknown), Ahrong Kim, Nari Shin, (unknown), Gi Yeong Huh	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact